Ace Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital
Ace Pharmaceuticals BV has been acquired by Gilde Buy Out Partners, Gilde Healthcare, Quadrum Capital and the management team.
Ace Pharmaceuticals is a leading pharmaceutical company in the niche of medical need products, and is based in Zeewolde, the Netherlands. As an independent company, Ace focuses on the development, production and distribution of licensed and unlicensed medicines. With its activities, Ace meets an essential social need: making and keeping scarce medication available for people for whom it is essential. It does so by actively collaborating with relevant stakeholders, including patient associations, doctors and governmental institutions. Since January 2020, Ace has also been supplying pharmaceutical compounding products to pharmacies in the Netherlands through its business unit Ace Compounding.
Oaklins’ debt advisory team in the Netherlands acted as advisor to the consortium and assisted in establishing a financing package aligned with the current business profile and future growth ambitions.



Jan Willem Popma
Director, Ace Pharmaceuticals BV
Talk to the deal team


Niels Vermuë
Oaklins Netherlands
Related deals
Seniovo GmbH has been acquired by HORNBACH Baumarkt AG
The shareholders of Seniovo GmbH have sold the company to HORNBACH Baumarkt AG.
Learn moreNordian Capital has raised debt to acquire Wetac
Nordian Capital, a Netherlands-based private equity firm, has joined the shareholder base of Wetac Battery Company (Wetac), a leading supplier of batteries, battery systems and accessories for various applications and end markets. The financing was provided by OLB and will support Wetac’s strong growth ambitions.
Learn moreNordian joins the shareholder base of Wetac to support further growth
Nordian, a Netherlands-based private equity firm, has joined the shareholder base of Wetac, a leading supplier of batteries and battery systems for various applications and end markets.
Learn more